CSRNP1 (cysteine and serine rich nuclear protein 1) is a transcriptional regulator with dual roles in cellular homeostasis and disease pathogenesis. The protein functions as a DNA-binding transcription factor that binds to consensus sequences and exhibits transcriptional activator activity 1. CSRNP1 demonstrates tissue-specific regulatory functions, selectively contributing to MMP1 expression in human chondrocytes through preferential binding to AP-1 consensus-like sequences in the MMP1 promoter, distinguishing it from MMP13 regulation 1. The protein plays critical roles in apoptosis and cellular stress responses through MAPK pathway activation. In hepatocellular carcinoma, CSRNP1 acts as a tumor suppressor by inducing mitochondrial dysfunction, increasing reactive oxygen species levels, and activating JNK/p38 MAPK signaling in a ROS-dependent manner 2. Conversely, CSRNP1 contributes to hepatic ischemia-reperfusion injury, where its inhibition reduces liver damage through MAPK pathway modulation 3. The gene is regulated by TGF-β1 signaling through SMAD3 activation 4 and shows circadian expression patterns in immune cells as part of vitamin D target gene networks 5. CSRNP1 expression is elevated in pelvic organ prolapse and contributes to collagen degradation and cellular senescence 6, highlighting its clinical relevance in tissue remodeling disorders.